WallStreetZenWallStreetZen

NASDAQ: IMCR
Immunocore Holdings PLC Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Immunocore Holdings earnings were -$21.6M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest IMCR earnings report on Mar 31, 2025 announced Q1 2025 earnings of $5.0M, down 121.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IMCR reported annual earnings of -$51.1M, with -7.6% growth. The next IMCR earnings date is Aug 6, 2025.

IMCR earnings history

Current Revenue
$333.6M
Current Earnings
-$21.6M
Current Profit Margin
-6.5%

IMCR Return on Equity

Current Company
-5.9%
Current Industry
-60.2%
Current Market
31.3%
IMCR's Return on Equity (-5.9%)... subscribe to Premium to read more.
High Return on Equity Performance

IMCR undefined

Current Company
-2.1%
Current Industry
-2.5%
IMCR is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when IMCR announces earnings.

IMCR undefined

Current Company
-0.47%
Current Industry
5.8%
IMCR has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IMCR vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
IMCR$1.93M-$21.63MN/A-$0.43
BCRX$47.59M-$53.47MN/A-$0.26
TARS-$93.78M-$104.94MN/A-$2.72
SPRY-$15.01M-$15.65MN/A-$0.17
LQDA-$110.63M-$127.83MN/A-$1.58
View Top Biotech Stocks

IMCR earnings dates

Next earnings date
Aug 6, 2025

Immunocore Holdings Earnings Reports & History FAQ

What were Immunocore Holdings's earnings last quarter?

On IMCR's earnings call on Invalid Date, Immunocore Holdings (NASDAQ: IMCR) reported Q1 2025 earnings per share (EPS) of $0.10, up 120.41% year over year. Total IMCR earnings for the quarter were $5.02 million. In the same quarter last year, Immunocore Holdings's earnings per share (EPS) was -$0.49.

If you're new to stock investing, here's how to buy Immunocore Holdings stock.

When does Immunocore Holdings report earnings?

The next IMCR earnings call is Invalid Date. Add IMCR to your watchlist to be reminded of Immunocore Holdings's next earnings date.

Is Immunocore Holdings profitable or losing money?

As of the last Immunocore Holdings earnings report, Immunocore Holdings is currently losing money. Immunocore Holdings's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$21.63 million, a 64.12% decrease year over year.

What was IMCR's earnings growth in the past year?

As of Immunocore Holdings's earnings date in Invalid Date, Immunocore Holdings's earnings has grown year over year. IMCR earnings in the past year totalled -$21.63 million.

What are Immunocore Holdings's earnings expectations?

The current EPS estimate for Immunocore Holdings's earnings report in Invalid Date is -$0.18.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.